phosphatidylcholines has been researched along with fluvoxamine in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (fluvoxamine) | Trials (fluvoxamine) | Recent Studies (post-2010) (fluvoxamine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 2,051 | 518 | 434 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | fluvoxamine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 0.54 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0038 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.54 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, AA; Dufourc, EJ; Gravel, AE; Marcotte, I | 1 |
| Ask, KS; Bardakci, T; Gjelstad, A; Halvorsen, TG; Parmer, MP; Pedersen-Bjergaard, S; Øiestad, EL | 1 |
2 other study(ies) available for phosphatidylcholines and fluvoxamine
| Article | Year |
|---|---|
An NMR investigation of the structure, function and role of the hERG channel selectivity filter in the long QT syndrome.
Topics: Bepridil; Cetirizine; Dimyristoylphosphatidylcholine; Diphenhydramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluvoxamine; Humans; Ion Channel Gating; Long QT Syndrome; Magnetic Resonance Spectroscopy; Membranes, Artificial; Phosphatidylcholines; Potassium; Promethazine; Protein Conformation; Structure-Activity Relationship | 2013 |
Parallel artificial liquid membrane extraction as an efficient tool for removal of phospholipids from human plasma.
Topics: Chromatography, Liquid; Fluoxetine; Fluvoxamine; Humans; Lysophosphatidylcholines; Membranes, Artificial; Pharmaceutical Preparations; Phosphatidylcholines; Phospholipids; Plasma; Quetiapine Fumarate; Sphingomyelins; Tandem Mass Spectrometry; Technology, Pharmaceutical | 2016 |